Skip to main content
SpringerLink
Log in

Donepezil-induced rhabdomyolysis

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fleet JL, et al. Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study. CMAJ: Canadian Medical Association Journal 191: E1018-E1024, No. 37, 16 Sep 2019. Available from: URL: https://doi.org/10.1503/cmaj.190337

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donepezil-induced rhabdomyolysis. Reactions Weekly 1772, 8 (2019). https://doi.org/10.1007/s40278-019-68135-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-68135-0

Search

Navigation